203 related articles for article (PubMed ID: 20930860)
21. An Essential Viral Transcription Activator Modulates Chromatin Dynamics.
Gibeault RL; Conn KL; Bildersheim MD; Schang LM
PLoS Pathog; 2016 Aug; 12(8):e1005842. PubMed ID: 27575707
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells.
Lee CY; Rennie PS; Jia WW
Clin Cancer Res; 2009 Aug; 15(16):5126-35. PubMed ID: 19671871
[TBL] [Abstract][Full Text] [Related]
23. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
[TBL] [Abstract][Full Text] [Related]
24. Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection.
Lium EK; Panagiotidis CA; Wen X; Silverstein S
J Virol; 1996 Jun; 70(6):3488-96. PubMed ID: 8648681
[TBL] [Abstract][Full Text] [Related]
25. Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0.
Zhu Z; Cai W; Schaffer PA
J Virol; 1994 May; 68(5):3027-40. PubMed ID: 8151771
[TBL] [Abstract][Full Text] [Related]
26. Replication-competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment.
Luo C; Mori I; Goshima F; Ushijima Y; Nawa A; Kimura H; Nishiyama Y
J Gene Med; 2007 Oct; 9(10):875-83. PubMed ID: 17685493
[TBL] [Abstract][Full Text] [Related]
27. Herpes simplex virus immediate-early proteins ICP0 and ICP4 activate the endogenous human alpha-globin gene in nonerythroid cells.
Cheung P; Panning B; Smiley JR
J Virol; 1997 Mar; 71(3):1784-93. PubMed ID: 9032307
[TBL] [Abstract][Full Text] [Related]
28. Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis.
Preston CM; Nicholl MJ
J Virol; 1997 Oct; 71(10):7807-13. PubMed ID: 9311867
[TBL] [Abstract][Full Text] [Related]
29. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
Lowry PW; Koropchak CM; Choi CY; Mocarski ES; Kern ER; Kinchington PR; Arvin AM
Antiviral Res; 1997 Feb; 33(3):187-200. PubMed ID: 9037375
[TBL] [Abstract][Full Text] [Related]
30. Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression.
Preston CM; Mabbs R; Nicholl MJ
Virology; 1997 Mar; 229(1):228-39. PubMed ID: 9123865
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus type 1 ICP4 deletion mutant virus d120 infection failed to induce apoptosis in nerve growth factor-differentiated PC12 cells.
Aiamkitsumrit B; Zhang X; Block TM; Norton P; Fraser NW; Su YH
J Neurovirol; 2007 Aug; 13(4):305-14. PubMed ID: 17849314
[TBL] [Abstract][Full Text] [Related]
32. The polyserine tract of herpes simplex virus ICP4 is required for normal viral gene expression and growth in murine trigeminal ganglia.
Bates PA; DeLuca NA
J Virol; 1998 Sep; 72(9):7115-24. PubMed ID: 9696805
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
34. The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection.
Desai P; Ramakrishnan R; Lin ZW; Osak B; Glorioso JC; Levine M
J Virol; 1993 Oct; 67(10):6125-35. PubMed ID: 8396674
[TBL] [Abstract][Full Text] [Related]
35. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
[TBL] [Abstract][Full Text] [Related]
36. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
37. Triple-mutated oncolytic herpes virus for treating both fast- and slow-growing tumors.
Fukuhara H; Takeshima Y; Todo T
Cancer Sci; 2021 Aug; 112(8):3293-3301. PubMed ID: 34036669
[TBL] [Abstract][Full Text] [Related]
38. Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate-early gene defects.
Thomas SK; Lilley CE; Latchman DS; Coffin RS
J Virol; 1999 Sep; 73(9):7399-409. PubMed ID: 10438830
[TBL] [Abstract][Full Text] [Related]
39. Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter.
Gu B; Rivera-Gonzalez R; Smith CA; DeLuca NA
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9528-32. PubMed ID: 8415735
[TBL] [Abstract][Full Text] [Related]
40. Differential cellular requirements for activation of herpes simplex virus type 1 early (tk) and late (gC) promoters by ICP4.
Zabierowski S; DeLuca NA
J Virol; 2004 Jun; 78(12):6162-70. PubMed ID: 15163709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
